Specialty Pharmacy

Exercise found to be one of the most important approaches for self-managing the consequences of multiple sclerosis.

Methotrexate discontinuation was not observed to impact rheumatoid arthritis treatment with tocilizumab, according to an abstract presented at the 2017 American College of Rheumatology Annual Meeting.

Alectinib (Alecensa) found to reduce the risk of disease progression in patients with metastatic non-small cell lung cancer.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses promising specialty drugs to watch out for in the pipeline.

Amazon entering pharmacy may transform pharmacy benefit managers.

Only 1% of women aged 20 to 68 years had an oral HPV infection.

Officials with the FDA have extended the approval of vemurafenib (Zelboraf, Genentech) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare blood cancer, making it the first approved treatment for ECD.

Some patients with rheumatoid arthritis require a refined treat-to-target plan.

Low incidence of 14-3-3η in patients with long-term RA, chronic HCV with arthralgias.

Treatment for psoriatic arthritis may impact symptoms and patient-reported outcomes.

An aspirin a day may reduce their risk of hepatocellular carcinoma in patients with hepatitis B virus.

Top news of the day from across the healthcare landscape.

Flares and immune-related adverse events are common among patients with rheumatologic diseases but can often be successfully managed.

Study finds improved mental health resources and non-pharmacologic treatment options may be effective in reducing reduce opioid exposure among children with juvenile fibromyalgia syndrome.

Patients with active psoriatic arthritis experience significant work instability based on disease activity.

Study finds high unmet need among patients with uncontrolled gout.

Biomarker identification may improve abatacept (Orencia) treatment for rheumatoid arthritis.

A look at last week's top stories in the world of pharmacy.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

Patients with rheumatoid arthritis who switched to biologics or triple therapy had a longer time to treatment failure versus augmented oral methotrexate.

Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.

Several modalities found to be effective in the triage of psoriasis patients with musculoskeletal symptoms, according to a study presented at the 2017 American College of Rheumatology meeting.

Current treatment options for dermatomyositis may be ineffective for some patients, according to a study presented at the American College of Rheumatology Annual Meeting.

Medivir to present positive data at the annual meeting of the American College of Rheumatology.

Top news of the day from across the healthcare landscape.

Vedolizumab (Entyvio) remains consistent in its safety profile in study of real-world data on ulcerative colitis and Crohn's disease.

Top news of the week from Specialty Pharmacy Times.

Unapproved products containing cannabidiol claim to prevent or cure cancer.

Changes to 340B reimbursement will drastically lower out-of-pocket costs for Medicare beneficiaries.

Glucose is crucial for the growth of brain cancer cells.